Literature DB >> 6830378

Serial pulmonary function in patients with acute heart failure.

R W Light, R B George.   

Abstract

This study delineates the effects of congestive heart failure on routine pulmonary function tests and assesses the changes in pulmonary function as congestive heart failure was treated. Twenty-eight patients had spirometry, lung volumes, and diffusing capacity measurements initially and at frequent intervals after their initial hospitalization for congestive heart failure. Initially the patients had both obstructive (mean forced expiratory volume in 1 s [FEV1], 48.2% +/- 13% predicted) and restrictive (mean forced vital capacity [FVC], 5.6% +/- 15.7% predicted) ventilatory dysfunction, but a normal carbon monoxide diffusing capacity. With treatment, pulmonary function rapidly improved initially and there was no further significant improvements in the mean pulmonary function after two weeks of treatment. However, there was marked interindividual variability and several patients took months to reach their best level of pulmonary function. Even with treatment, the patients retained evidence of obstructive ventilatory dysfunction and at the time of their best spirometry 53% (8/15) of nonsmokers still had an abnormally low FEV1/FVC ratio.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830378

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  26 in total

1.  Effects of respiratory muscle work on blood flow distribution during exercise in heart failure.

Authors:  Thomas P Olson; Michael J Joyner; Niki M Dietz; John H Eisenach; Timothy B Curry; Bruce D Johnson
Journal:  J Physiol       Date:  2010-05-10       Impact factor: 5.182

Review 2.  Pathophysiology and treatment of Cheyne-Stokes respiration.

Authors:  M T Naughton
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

Review 3.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

4.  The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates.

Authors:  O A Al-Rawas; R Carter; R D Stevenson; S K Naik; D J Wheatley
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

5.  Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jelena Čelutkienė; Mindaugas Balčiūnas; Denis Kablučko; Liucija Vaitkevičiūtė; Jelena Blaščiuk; Edvardas Danila
Journal:  Card Fail Rev       Date:  2017-04

6.  Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.

Authors:  Richard Steinacher; John T Parissis; Bernhard Strohmer; Jörg Eichinger; Dennis Rottlaender; Uta C Hoppe; Johann Altenberger
Journal:  Clin Res Cardiol       Date:  2012-03-07       Impact factor: 5.460

Review 7.  Obstructive Ventilatory Disorder in Heart Failure-Caused by the Heart or the Lung?

Authors:  Sergio Caravita; Jean-Luc Vachiéry
Journal:  Curr Heart Fail Rep       Date:  2016-12

8.  Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).

Authors:  Robert J Mentz; Phillip J Schulte; Jerome L Fleg; Mona Fiuzat; William E Kraus; Ileana L Piña; Steven J Keteyian; Dalane W Kitzman; David J Whellan; Stephen J Ellis; Christopher M O'Connor
Journal:  Am Heart J       Date:  2012-11-28       Impact factor: 4.749

9.  Pulmonary function changes associated with cardiomegaly in chronic heart failure.

Authors:  Thomas P Olson; Kenneth C Beck; Bruce D Johnson
Journal:  J Card Fail       Date:  2007-03       Impact factor: 5.712

10.  Airway and cough responsiveness and exhaled nitric oxide in non-smoking patients with stable chronic heart failure.

Authors:  T P Chua; U G Lalloo; M Y Worsdell; S Kharitonov; K F Chung; A J Coats
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.